Position in ATNM
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$106,575
-$39,123 QoQ
Shares Held
107,111
-0.0% QoQ
Ownership
0.341%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gen-Wealth Partners Inc holds $1,702,372 across 16 Biotechnology names. ATNM ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QNCX |
Quince Therapeutics, Inc.
|
33,018 | $666,963 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
47,176 | $604,796 | |
| 3 | ARGX |
Argenx SE
|
230 | $167,957 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184 | $142,165 | |
| 5 | ATNM |
Actinium Pharmaceuticals, Inc.
This page
|
107,111 | $106,575 | |
| 6 | TNXP |
Tonix Pharmaceuticals Holding Corp.
|
533 | $7,328 | |
| 7 | ITRMF |
Iterum Therapeutics plc
|
82,617 | $2,478 | |
| 8 | MRNA |
Moderna, Inc.
|
25 | $1,270 |
All Filings in ATNM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,575 | 107,111 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $145,698 | 107,131 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $175,009 | 109,381 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||